Teng Wei Chen
Director/Board Member bei AIMFINITY INVESTMENT CORP. I
Profil
Teng Wei Chen is an Independent Director at Aimfinity Investment Corp.
I and Inkstone Feibo Acquisition Corp.
He is also a Director at New-Shine Biomedical Co., Ltd.
Dr. Chen holds a doctorate degree from China Medical University (Taiwan).
Aktive Positionen von Teng Wei Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| AIMFINITY INVESTMENT CORP. I | Director/Board Member | 17.03.2023 |
Inkstone Feibo Acquisition Corp.
 Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Director/Board Member | - |
| New-Shine Biomedical Co., Ltd. | Director/Board Member | 01.01.2018 |
Ausbildung von Teng Wei Chen
| China Medical University (Taiwan) | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| AIMFINITY INVESTMENT CORP. I | Finance |
| Private Unternehmen | 2 |
|---|---|
Inkstone Feibo Acquisition Corp.
Inkstone Feibo Acquisition Corp. Financial ConglomeratesFinance Inkstone Feibo Acquisition Corp. is a blank check company, which engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. It focuses on opportunities in biotechnology and green technology industries with an emphasize on environmental, social, and governance (ESG) practices in the United States and Taiwan. The company was founded on April 20, 2022 and is headquartered in Wilmington, DE. | Finance |
| New-Shine Biomedical Co., Ltd. |
